BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15871166)

  • 21. Recent HIV-1 Outbreak Among Intravenous Drug Users in Romania: Evidence for Cocirculation of CRF14_BG and Subtype F1 Strains.
    Niculescu I; Paraschiv S; Paraskevis D; Abagiu A; Batan I; Banica L; Otelea D
    AIDS Res Hum Retroviruses; 2015 May; 31(5):488-95. PubMed ID: 25369079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV RNA viral load and CD4+ T-cell counts in HIV-infected pregnant women with and without treatment discontinuation in early pregnancy.
    Tamburrini E; Ravizza M; Floridia M; Tibaldi C; Alberico S; Anzidei G; Maccabruni A; Meloni A; Antoni AD; Mori F; Dalzero S; Conservan V; Pinnetti C; Ferrazzi E;
    Antivir Ther; 2008; 13(4):519-27. PubMed ID: 18672530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads.
    Baeten JM; Chohan B; Lavreys L; Chohan V; McClelland RS; Certain L; Mandaliya K; Jaoko W; Overbaugh J
    J Infect Dis; 2007 Apr; 195(8):1177-80. PubMed ID: 17357054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of MIP-1beta and RANTES in HIV-1 subtype CRF01_AE infected patients with different rates of disease progression.
    Chuenchitra T; Wasi C; de Souza M; Nitayaphan S; Louisirirotchanakul S; Sutthent R; Brown AE; Birx DL; Polonis VR
    Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):856-62. PubMed ID: 19058580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.
    Breton G; Lewden C; Spire B; Salmon D; Brun-Vézinet F; Duong M; Allavena C; Leport C; Salamon R;
    HIV Med; 2007 Apr; 8(3):164-70. PubMed ID: 17461860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection and quantification of proviral HIV-1 184 M/V in circulating CD4(+) T cells of patients on HAART with a viremia less than 1,000 copies/ml.
    Mohey R; Jørgensen LB; Møller BK; Black FT; Kjems J; Obel N
    J Clin Virol; 2005 Dec; 34(4):257-67. PubMed ID: 16286049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serological approaches to subtyping of HIV-1 in injecting drug users in Russia: evidence of subtype homogeneity at the main sites of the epidemic.
    Bobkova MR; Kazennova EV; Selimova LM; Buravtsova EV; Lister S; Prilipov AG; Weber JN; Pokrovsky VV; Bobkov AF
    Int J STD AIDS; 2001 Jan; 12(1):34-40. PubMed ID: 11177480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam.
    Liao H; Tee KK; Hase S; Uenishi R; Li XJ; Kusagawa S; Thang PH; Hien NT; Pybus OG; Takebe Y
    Virology; 2009 Aug; 391(1):51-6. PubMed ID: 19540543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-reactive T cell responses in HIV CRF01_AE and B'-infected intravenous drug users: implications for superinfection and vaccines.
    Promadej-Lanier N; Thielen C; Hu DJ; Chaowanachan T; Gvetadze R; Choopanya K; Vanichseni S; McNicholl JM
    AIDS Res Hum Retroviruses; 2009 Jan; 25(1):73-81. PubMed ID: 19182923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Women infected with HIV type 1 Brazilian variant, subtype B (B'-GWGR motif) have slower progression to AIDS, compared with patients infected with subtype B (B-GPGR motif).
    de Brito A; Komninakis SC; Novoa P; de Oliveira RM; Fonseca LA; Duarte AJ; Casseb J
    Clin Infect Dis; 2006 Dec; 43(11):1476-81. PubMed ID: 17083025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Estimate of the number of HIV-infected intravenous drug users in Amsterdam].
    van Haastrecht HJ; Bindels PJ; van den Hoek JA; Coutinho RA
    Ned Tijdschr Geneeskd; 1992 Jun; 136(23):1111-4. PubMed ID: 1603172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CMV DNA levels and CMV gB subtypes in ART-naive HAART-treated patients: a 2-year follow-up study in The Netherlands.
    Goossens VJ; Wolffs PF; van Loo IH; Bruggeman CA; Verbon A
    AIDS; 2009 Jul; 23(11):1425-9. PubMed ID: 19531930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Syphilis and human immunodeficiency virus (HIV)-1 coinfection: influence on CD4 T-cell count, HIV-1 viral load, and treatment response.
    Kofoed K; Gerstoft J; Mathiesen LR; Benfield T
    Sex Transm Dis; 2006 Mar; 33(3):143-8. PubMed ID: 16505739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of unprotected sex among Finnish HIV-positive and HIV-negative injecting drug users.
    Kivelä PS; Krol A; Partanen AL; Ristola MA
    Scand J Public Health; 2009 Jun; 37(4):357-63. PubMed ID: 19372233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
    Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
    Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.
    Liu J; Yue J; Wu S; Yan Y
    Arch Virol; 2007; 152(10):1799-805. PubMed ID: 17619115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
    Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
    AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The spread of HIV-1 subtypes B and CRF01_AE among injecting drug users in Bangkok, Thailand.
    Xiridou M; van Griensven F; Tappero JW; Martin M; Gurwith M; Vanichseni S; Kittikraisak W; Coutinho R; Choopanya K
    J Acquir Immune Defic Syndr; 2007 Aug; 45(4):468-75. PubMed ID: 17496560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 infection among injection and ex-injection drug users from Rio de Janeiro, Brazil: prevalence, estimated incidence and genetic diversity.
    Teixeira SL; Bastos FI; Telles PR; Hacker MA; Brigido LF; de F Oliveira CA; Bongertz V; Morgado MG
    J Clin Virol; 2004 Nov; 31(3):221-6. PubMed ID: 15465416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of GB virus C on response to antiretroviral therapy in HIV-infected Brazilians.
    Souza IE; Zhang W; Diaz RS; Chaloner K; Klinzman D; Stapleton JT
    HIV Med; 2006 Jan; 7(1):25-31. PubMed ID: 16313289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.